Department of Otorhinolaryngology-Head and Neck Surgery, Medical University of Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
Department of Medical Psychology, Medical University of Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
Eur Arch Otorhinolaryngol. 2020 May;277(5):1437-1448. doi: 10.1007/s00405-020-05807-0. Epub 2020 Jan 25.
Surgical rescue is a treatment option for persistent disease after first-line treatment treatment of head and neck cancer (HNC).
Patients with persistent HNC treated with rescue surgery between 2008 and 2016 were included. Patients who received a rescue neck dissection (ND only) and who received primary site surgery ± ND were analysed separately (primary site surgery ± ND).
During the observation period, 35 patients received ND only and 17 primary site surgery ± ND. No perioperative mortality was observed. In nine patients with ND only and 12 patients with primary site surgery ± ND at least one complication was encountered. 41/52 (79%) patients had a complete response. Median overall survival of patients receiving rescue surgery was 56 months (95% CI 44-69 months). Median overall survival was best for patients with initial laryngeal and oropharyngeal cancer and worst for patients with hypopharyngeal cancer (p = 0.02). Functional deficits following rescue surgery were mainly observed in the domains speech, nutrition, and shoulder/arm mobility. The risk of functional impairment was higher for patients with rescue surgery at the primary tumor site (OR 2.5 ± 2; p = 0.07).
Rescue surgery offers patients with resectable, persistent disease a realistic chance to achieve long-term survival. Especially patients with laryngeal and oropharyngeal cancer profited from rescue surgery. Rescue neck dissection is an effective and safe procedure. Patients with rescue surgery at the primary tumor site ± ND should expect complications and permanent functional impairment.
手术挽救治疗是头颈部癌症(HNC)一线治疗后持续性疾病的一种治疗选择。
纳入 2008 年至 2016 年间接受挽救性手术治疗的持续性 HNC 患者。分别分析仅接受挽救性颈清扫术(仅 ND)和接受原发灶手术±ND 的患者(原发灶手术±ND)。
在观察期间,35 例患者仅接受 ND,17 例患者接受原发灶手术±ND。未观察到围手术期死亡。在仅 ND 的 9 例患者和原发灶手术±ND 的 12 例患者中,至少有 1 例发生并发症。41/52(79%)例患者有完全缓解。接受挽救性手术的患者中位总生存时间为 56 个月(95%CI 44-69 个月)。初始喉和口咽癌患者的中位总生存率最佳,而下咽癌患者最差(p=0.02)。挽救性手术后的功能缺陷主要发生在言语、营养和肩部/手臂活动度等领域。在原发肿瘤部位接受挽救性手术的患者功能损害的风险更高(OR 2.5±2;p=0.07)。
挽救性手术为可切除的持续性疾病患者提供了实现长期生存的现实机会。特别是喉和口咽癌患者从挽救性手术中获益。挽救性颈清扫术是一种有效且安全的手术。在原发肿瘤部位±ND 接受挽救性手术的患者应预计会发生并发症和永久性功能损害。